Literature DB >> 10704758

Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats.

M Virgili1, A Contestabile.   

Abstract

The antioxidant compound trans-resveratrol, is found in substantial amount in several types of red wine and is considered one of the substances responsible for the lower incidence of coronary heart diseases among regular consumers of such wines, an effect also known as the French paradox. It has also been proposed that resveratrol may have beneficial effects against neurodegenerative diseases. We report here that chronic administration of resveratrol to young-adult rats, significantly protects from the damage caused by systemic injection of the excitotoxin kainic acid, in the olfactory cortex and the hippocampus. The same treatment, however, is not able to give any significant protection in an ex vivo model of simulated ischemia on hippocampal slices in vitro. This first evidence of a partial neuroprotective action of chronic administration of resveratrol in vivo, suggests that other models of neurodegenerative injury, and in particular of excitotoxic brain damage, should be investigated in order to assess the potentiality for resveratrol to be used as a pharmacological tool for neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704758     DOI: 10.1016/s0304-3940(00)00820-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  55 in total

1.  Resveratrol Represses Pokemon Expression in Human Glioma Cells.

Authors:  Yutao Yang; Jiajun Cui; Feng Xue; Anne-Marie Overstreet; Yiping Zhan; Dapeng Shan; Hui Li; Hui Li; Yongjun Wang; Mengmeng Zhang; Chunjiang Yu; Zhi-Qing David Xu
Journal:  Mol Neurobiol       Date:  2015-01-27       Impact factor: 5.590

Review 2.  Resveratrol neuroprotection in stroke and traumatic CNS injury.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2015-08-12       Impact factor: 3.921

3.  EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol.

Authors:  Zhenquan Jia; Hong Zhu; Bhaba R Misra; James E Mahaney; Yunbo Li; Hara P Misra
Journal:  Mol Cell Biochem       Date:  2008-04-13       Impact factor: 3.396

4.  Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.

Authors:  Tim West; Madeliene Atzeva; David M Holtzman
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

Review 5.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Protective effects of resveratrol on glutamate-induced damages in murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2013-03-05       Impact factor: 3.575

Review 7.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

8.  Neuroprotective properties of Valeriana officinalis extracts.

Authors:  João O Malva; Sandra Santos; Tice Macedo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 9.  The biological responses to resveratrol and other polyphenols from alcoholic beverages.

Authors:  Lindsay Brown; Paul A Kroon; Dipak K Das; Samarjit Das; Arpad Tosaki; Vincent Chan; Manfred V Singer; Peter Feick
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

10.  Resveratrol preserves cerebrovascular density and cognitive function in aging mice.

Authors:  Charlotte A Oomen; Eszter Farkas; Viktor Roman; Eline M van der Beek; Paul G M Luiten; Peter Meerlo
Journal:  Front Aging Neurosci       Date:  2009-12-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.